HENDERA
831152
Hengerda New Materials
300946
Fujian Nebula Electronics.,Ltd
300648
4
Cubic Digital Technology
300344
5
HNAC Technology
300490
US Stock MarketDetailed Quotes
TSHA Taysha Gene Therapies
- 1.6700
- +0.0400+2.45%
Trading Feb 18 11:54 ET
342.26MMarket Cap2.65P/E (TTM)
1.7350High1.6400Low677.69KVolume1.6400Open1.6300Pre Close1.14MTurnover0.59%Turnover RatioLossP/E (Static)204.94MShares4.320052wk High3.86P/B191.88MFloat Cap1.190052wk Low--Dividend TTM114.90MShs Float33.3500Historical High--Div YieldTTM5.83%Amplitude0.5000Historical Low1.6780Avg Price1Lot Size
Taysha Gene Therapies News
Taysha Gene Therapies | 10-Q: Q3 2024 Earnings Report
Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Taysha Gene Therapies | 10-Q: Q2 2024 Earnings Report
Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update
Taysha Gene Therapies | 10-Q: Q1 2024 Earnings Report
Taysha Gene Therapies | 10-K: FY2023 Annual Report
Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
Taysha Gene Therapies | 10-Q: Q3 2023 Earnings Report
Taysha Gene Therapies | 10-Q: Q2 2023 Earnings Report
Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports Initial Clinical Data from First Adult Rett Syndrome Patient Dosed in REVEAL Phase 1/2 Trial and Provides Corporate Update with Second Quarter 2023 Financial Results
Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update
Taysha Gene Therapies | 10-Q: Q1 2023 Earnings Report
Taysha Gene Therapies | 10-K/A: Annual report (Amendment)
Taysha Gene Therapies | 10-K: FY2022 Annual Report
Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Taysha Gene Therapies | 10-Q: Q3 2022 Earnings Report
Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Taysha Gene Therapies | 10-Q: Q2 2022 Earnings Report
Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Trending Stocks
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call